# Paterna Biosciences, Inc. — Form D

Paterna Biosciences, Inc. of MORRISTOWN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-29. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-09-29
- Form: D
- Accession: 0001013594-22-000612
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.0M
- Remaining: $2.0M
- Investors: 1
- Date of first sale: 2022-09-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-460240

## Issuer

- Name: Paterna Biosciences, Inc.
- CIK: 0001947951
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 89 HEADQUARTERS PLAZA, MORRISTOWN, NJ, 07960
- Phone: 9734629695

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Deirdre Conway | Director | Morristown, NJ |
| James Hotaling | Director | Salt Lake City, UT |
| Cythia Tsai | Director | Morristown, NJ |
| Danny Mitchell | Executive Officer | Salt Lake City, UT |
| Edward Rowland | Executive Officer | Madison, NJ |

## More

- [CIK 1947951 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1947951&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001013594-22-000612.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.